The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
Gámez B., Morris EV., Olechnowicz SWZ., Webb S., Edwards JR., Sowman A., Turner CJ., Edwards CM.